VK-1430

N/A

Report date: 2022/01/25 17:06:08
NME

Base Information

Drug NameVK-1430
Drug Alias NameVK-1430
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase inhibitors
TargetsDiacylglycerol O-acyltransferase
Therapy Area/IndicationsHypertriglyceridemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesViking Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A